![Dylan Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dylan Harmon
Investitore di Private Equity presso
H.I.G. BioHealth Partners LLC
Profilo
Dylan Harmon joined CRG in 2019 and is a member of the Investment Team.
Mr. Harmon’s primary responsibilities are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio companies.
Prior to joining CRG, Mr. Harmon served on the Investment Team at Longitude Capital.
There he focused on investing in biotechnology companies and was actively involved in portfolio company operations.
Previously, Mr. Harmon was a member of the Healthcare Investment Banking Group at Bank of America Merrill Lynch.
Mr. Harmon received a Bachelor's degree in Applied Economics and Management from Cornell University and an MBA in Health Care Management from the Wharton School at the University of Pennsylvania.
Posizioni attive di Dylan Harmon
| Società | Posizione | Inizio |
|---|---|---|
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in companies located in the United States. The firm targets companies operating in the field of medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It provides financing for acquisition, IPO and growth stage capital requirements in the form of equity and debt. It also makes follow on investments. | Investitore di Private Equity | 01/01/2022 |
Precedenti posizioni note di Dylan Harmon
| Società | Posizione | Fine |
|---|---|---|
CR Group LP
 CR Group LP Investment ManagersFinance CRG invests in both public and private small & middle market companies located across the globe, primarily in the United States, Europe, Australia and Canada with revenues under USD 300 million. The firm targets companies operating in the fields of consumer health, life sciences, and healthcare services & IT. sectors. It provides financing in the form of debt and equity for growth transactions with an investment size ranging from USD 20 to 300 million. | Investitore di Private Equity | 01/01/2022 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/12/2014 |
| TEARLAB CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Dylan Harmon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
94
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
TearLab Corp., Inc.
 TearLab Corp., Inc. Medical SpecialtiesHealth Technology Develops point-of-care portable devices for measuring osmolarity to treat eye disorders | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in companies located in the United States. The firm targets companies operating in the field of medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It provides financing for acquisition, IPO and growth stage capital requirements in the form of equity and debt. It also makes follow on investments. | Finance |
CR Group LP
CR Group LP Investment ManagersFinance CRG invests in both public and private small & middle market companies located across the globe, primarily in the United States, Europe, Australia and Canada with revenues under USD 300 million. The firm targets companies operating in the fields of consumer health, life sciences, and healthcare services & IT. sectors. It provides financing in the form of debt and equity for growth transactions with an investment size ranging from USD 20 to 300 million. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
